![Melissa K. Carpenter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa K. Carpenter
Directeur/Membre du Conseil chez The International Society for Stem Cell Research
Postes actifs de Melissa K. Carpenter
Sociétés | Poste | Début | Fin |
---|---|---|---|
The International Society for Stem Cell Research | Directeur/Membre du Conseil | 18/03/2021 | - |
Historique de carrière de Melissa K. Carpenter
Anciens postes connus de Melissa K. Carpenter
Sociétés | Poste | Début | Fin |
---|---|---|---|
Proteus RM LLC (Venture Capital)
![]() Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Private Equity Investor | 22/09/2010 | - |
CytoTherapuetics, Inc. | Corporate Officer/Principal | - | - |
CyThera, Inc.
![]() CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
GERON CORPORATION | Corporate Officer/Principal | - | - |
ViaCyte, Inc.
![]() ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/01/2006 | - |
Formation de Melissa K. Carpenter
University of California, Irvine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Finance | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
GERON CORPORATION | Health Technology |
Entreprise privées | 5 |
---|---|
ViaCyte, Inc.
![]() ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
CyThera, Inc.
![]() CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Commercial Services |
CytoTherapuetics, Inc. | Finance |
Proteus RM LLC (Venture Capital)
![]() Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
The International Society for Stem Cell Research |
- Bourse
- Insiders
- Melissa K. Carpenter
- Expérience